These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 7488449)
1. Failure of "effective" treatment for heart failure to improve normal customary activity. Walsh JT; Andrews R; Evans A; Cowley AJ Br Heart J; 1995 Oct; 74(4):373-6. PubMed ID: 7488449 [TBL] [Abstract][Full Text] [Related]
2. Comparison of captopril and ibopamine in mild to moderate heart failure. Dohmen HJ; Dunselman PH; Poole-Wilson PA Heart; 1997 Sep; 78(3):285-90. PubMed ID: 9391292 [TBL] [Abstract][Full Text] [Related]
3. Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study. Lewis BS; Rabinowitz B; Schlesinger Z; Caspi A; Markiewicz W; Rosenfeld T; Sclarovsky S; Ermer W Cardiology; 1999; 91(1):1-7. PubMed ID: 10393392 [TBL] [Abstract][Full Text] [Related]
4. Failure of an ACE inhibitor to improve exercise tolerance. A randomized study of trandolapril. Trandolapril study group. Hampton JR; Cowley AJ; Wnuk-Wojnar AM Eur Heart J; 1998 Dec; 19(12):1823-8. PubMed ID: 9886725 [TBL] [Abstract][Full Text] [Related]
5. Assessing exercise capacity, quality of life and haemodynamics in heart failure: do the tests tell us the same thing? Houghton AR; Harrison M; Cowley AJ; Hampton JR Eur J Heart Fail; 2002 Jun; 4(3):289-95. PubMed ID: 12034154 [TBL] [Abstract][Full Text] [Related]
6. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group. Ziesche S; Cobb FR; Cohn JN; Johnson G; Tristani F Circulation; 1993 Jun; 87(6 Suppl):VI56-64. PubMed ID: 8500241 [TBL] [Abstract][Full Text] [Related]
7. A comparison of the effects of captopril and flosequinan in patients with severe heart failure. Cowley AJ; Wynne RD; Swami A; Birkhead J; Skene A; Hampton JR Cardiovasc Drugs Ther; 1992 Oct; 6(5):465-70. PubMed ID: 1450090 [TBL] [Abstract][Full Text] [Related]
8. Effects of enoximone in patients with heart failure uncontrolled by captopril and diuretics. Cowley AJ; Stainer K; Fullwood L; Muller AF; Hampton JR Int J Cardiol; 1990 Jul; 28 Suppl 1():S45-52; discussion 52-3. PubMed ID: 2145238 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Bharani A; Ganguli A; Mathur LK; Jamra Y; Raman PG Indian Heart J; 2002; 54(2):170-5. PubMed ID: 12086380 [TBL] [Abstract][Full Text] [Related]
10. Exercise tolerance in patients with heart failure--how should it be measured? Cowley AJ; Fullwood L; Stainer K; Hampton JR Eur Heart J; 1991 Jan; 12(1):50-4. PubMed ID: 2009893 [TBL] [Abstract][Full Text] [Related]
11. Lack of effect of nitrates on exercise tolerance in patients with mild to moderate heart failure caused by coronary disease already treated with captopril. Wieshammer S; Hetzel M; Hetzel J; Kochs M; Hombach V Br Heart J; 1993 Jul; 70(1):17-21. PubMed ID: 8037993 [TBL] [Abstract][Full Text] [Related]
12. [Functional activity of platelet guanylate cyclase and cardiac hemodynamics in patients with chronic heart failure and relevant changes after treatment with isosorbide-5-mononitrate]. Ol'binskaia LI; Ushakova AV; Sizova ZhM Ter Arkh; 1999; 71(9):77-9. PubMed ID: 10553632 [TBL] [Abstract][Full Text] [Related]
13. Effects of chronic nitrate therapy on left-ventricular volume in patients with heart failure secondary to coronary disease already treated with captopril: a withdrawal study. Wieshammer S; Hetzel M; Hetzel J; Henze E; Hombach V Cardiology; 2001; 95(2):61-5. PubMed ID: 11423708 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of cilazapril and captopril versus placebo on exercise testing in chronic heart failure patients: a double-blind, randomized, multicenter trial. The Cilazapril-Captopril Multicenter Group. Cardiology; 1995; 86 Suppl 1():34-40. PubMed ID: 7614505 [TBL] [Abstract][Full Text] [Related]
16. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Ghose JC; Chakraborty S; Mondal M; Bhandari B J Assoc Physicians India; 1993 May; 41(5):269-71. PubMed ID: 8300456 [TBL] [Abstract][Full Text] [Related]
17. [The impact of nitrates and mono-therapy and nitrates combined with angiotensin converting enzyme inhibitors on left ventricular remodeling and exercise capacity in patients after acute myocardial infarction]. Maciejewicz J; Maziarz A; Celibała R; Wiśniewski M; Wiśniewska M Przegl Lek; 2003; 60(2):80-4. PubMed ID: 12939852 [TBL] [Abstract][Full Text] [Related]
18. Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure. Northridge DB; Currie PF; Newby DE; McMurray JJ; Ford M; Boon NA; Dargie HJ Eur J Heart Fail; 1999 Mar; 1(1):67-72. PubMed ID: 10937982 [TBL] [Abstract][Full Text] [Related]
19. Reversal of heart failure remodeling in women. Levine TB; Levine AB; Kaminski P; Stomel RJ J Womens Health Gend Based Med; 2000 Jun; 9(5):513-9. PubMed ID: 10883943 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the immediate and long-term effects of captopril and isosorbide dinitrate as adjunctive treatment in mild heart failure. Wilkes NP; Barin E; Hoschl R; Stokes GS; Nelson GI Br J Clin Pharmacol; 1989 Oct; 28(4):427-34. PubMed ID: 2686737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]